Janney Montgomery Scott
PGEN icon

Janney Montgomery Scott’s Precigen PGEN Stock Holding History

Janney Montgomery Scott’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
28,163
+1,100
+4% +$4.75K ﹤0.01% 3023
2026
Q1 		$105K Sell
27,063
-3,225
-11% -$13.2K ﹤0.01% 2699
2025
Q4 		$127K Buy
30,288
+275
+0.9% +$1.06K ﹤0.01% 2852
2025
Q3 		$99K Hold
30,013
– – ﹤0.01% 2810
2025
Q2 		$43K Sell
30,013
-1,500
-5% -$2.13K ﹤0.01% 2680
2025
Q1 		$47K Buy
31,513
+300
+1% +$472 ﹤0.01% 2639
2024
Q4 		$35K Sell
31,213
-1,400
-4% -$1.19K ﹤0.01% 2666
2024
Q3 		$31K Hold
32,613
– – ﹤0.01% 2627
2024
Q2 		$52K Sell
32,613
-400
-1% -$581 ﹤0.01% 2560
2024
Q1 		$48K Sell
33,013
-7,030
-18% -$10.1K ﹤0.01% 2680
2023
Q4 		$54K Sell
40,043
-1,533
-4% -$1.8K ﹤0.01% 2581
2023
Q3 		$59K Buy
41,576
+500
+1% +$709 ﹤0.01% 2507
2023
Q2 		$47K Sell
41,076
-4,737
-10% -$5.59K ﹤0.01% 2594
2023
Q1 		$49K Sell
45,813
-9,863
-18% -$14.2K ﹤0.01% 2407
2022
Q4 		$85K Sell
55,676
-150
-0.3% -$258 ﹤0.01% 2487
2022
Q3 		$118K Buy
55,826
+1,675
+3% +$3.53K ﹤0.01% 2389
2022
Q2 		$78K Sell
54,151
-1,575
-3% -$2.34K ﹤0.01% 2263
2022
Q1 		$118K Sell
55,726
-2,542
-4% -$6.19K ﹤0.01% 2163
2021
Q4 		$216K Buy
58,268
+1,175
+2% +$5.06K ﹤0.01% 2191
2021
Q3 		$285K Buy
57,093
+5,950
+12% +$34.3K ﹤0.01% 1989
2021
Q2 		$333K Buy
51,143
+15,900
+45% +$111K ﹤0.01% 1859
2021
Q1 		$243K Buy
35,243
+275
+0.8% +$2.33K ﹤0.01% 1966
2020
Q4 		$357K Sell
34,968
-4,800
-12% -$31.1K ﹤0.01% 1778
2020
Q3 		$139K Buy
39,768
+205
+0.5% +$973 ﹤0.01% 1969
2020
Q2 		$197K Sell
39,563
-950
-2% -$3.23K ﹤0.01% 1837
2020
Q1 		$138K Sell
40,513
-445
-1% -$1.92K ﹤0.01% 1741
2019
Q4 		$224K Sell
40,958
-1,850
-4% -$10.4K ﹤0.01% 1867
2019
Q3 		$245K Buy
42,808
+1,193
+3% +$8.11K ﹤0.01% 1795
2019
Q2 		$319K Buy
41,615
+11,825
+40% +$63.7K ﹤0.01% 1668
2019
Q1 		$157K Sell
29,790
-99,789
-77% -$692K ﹤0.01% 1901
2018
Q4 		$847K Buy
129,579
+13,718
+12% +$154K 0.01% 1014
2018
Q3 		$2M Sell
115,861
-59,892
-34% -$891K 0.02% 698
2018
Q2 		$2.45M Sell
175,753
-3,653
-2% -$61.7K 0.02% 597
2018
Q1 		$2.75M Buy
179,406
+9,078
+5% +$130K 0.03% 545
2017
Q4 		$1.96M Sell
170,328
-51,437
-23% -$766K 0.02% 650
2017
Q3 		$4.22M Sell
221,765
-798
-0.4% -$16.4K 0.05% 377
2017
Q2 		$5.36M Sell
222,563
-6,592
-3% -$145K 0.07% 308
2017
Q1 		$4.54M Sell
229,155
-26,303
-10% -$587K 0.06% 322
2016
Q4 		$6.15M Sell
255,458
-59,215
-19% -$1.65M 0.09% 235
2016
Q3 		$8.74M Buy
+314,673
New +$8.32M 0.15% 159
2016
Q2 		– Sell
-378,702
Closed -$12.7M – 1034
2016
Q1 		$12.7M Buy
378,702
+38,877
+11% +$1.22M 0.33% 71
2015
Q4 		$10.2M Buy
339,825
+177,700
+110% +$5.99M 0.26% 91
2015
Q3 		$5.11M Buy
162,125
+8,297
+5% +$405K 0.14% 170
2015
Q2 		$7.44M Buy
153,828
+85,897
+126% +$3.62M 0.16% 149
2015
Q1 		$2.95M Buy
67,931
+3,834
+6% +$138K 0.05% 413
2014
Q4 		$1.69M Sell
64,097
-2,355
-4% -$51.6K 0.03% 620
2014
Q3 		$1.18M Sell
66,452
-6,772
-9% -$138K 0.02% 750
2014
Q2 		$1.76M Buy
73,224
+28,351
+63% +$575K 0.04% 567
2014
Q1 		$1.13M Buy
+44,873
New +$1.24M 0.03% 700

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janney Montgomery Scott's PGEN Position: Q2 2026 in Review

Janney Montgomery Scott increased its Precigen (PGEN) stake by 4.1% in Q2 2026, buying an estimated $4.75K and bringing the position to 28,163 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

Janney Montgomery Scott first reported a position in PGEN in Q1 2014 and has held it in 49 quarters since. The position peaked at $12.7M in Q1 2016. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Janney Montgomery Scott held 28,163 shares of Precigen worth $161K as of Q2 2026.
  • Janney Montgomery Scott bought 1,100 Precigen shares in Q2 2026, an estimated $4.75K.
  • Precigen made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #3023 holding.
  • Janney Montgomery Scott first reported a position in Precigen in Q1 2014 and has held it in 49 quarters since.
  • Janney Montgomery Scott's Precigen position peaked at $12.7M in Q1 2016.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.